Skip to content
Mesothelioma.net
phone iconCall1-800-692-8608 chat icon Chat 24/7 Live Chat
Menu
  • Malignant Mesothelioma
    • About Mesothelioma
      • How to Survive Mesothelioma
      • 100 Questions & Answers about Mesothelioma (Free Book)
      • Symptoms
      • Diagnosis
      • Prognosis
      • Life Expectancy
    • Types
      • Pleural
      • Peritoneal
      • Epithelioid
      • Sarcomatoid
      • Biphasic
    • Stages
      • Stage 1
      • Stage 2
      • Stage 3
      • Stage 4
    • Additional Information
      • Causes
      • Asbestos and Its Dangers
      • Facts
      • Support
      • Financial Compensation
      • FREE Mesothelioma Packet
  • Treatment
    • Treatment Options
      • Surgery
      • Chemotherapy
      • Radiation Therapy
      • Multimodal Therapy
      • Medications
      • Palliative Treatment
    • Find Top Doctors
      • Doctors
      • Treatment Centers
      • Treatment & Doctors Near You
      • New Treatments
      • Care Providers
      • Clinical Trials
      • Costs
  • Asbestos Trusts
  • Compensation
  • Veteran Assistance
    • Mesothelioma and Veterans
      • VA Claims for Mesothelioma
      • Vietnam Veterans
    • Military Branches and Asbestos
      • Navy Veterans
      • Navy Ships
      • Marine Corps Veterans
      • Army Veterans
      • Air Force Veterans
      • U.S. Coast Guard
  • Surviving Mesothelioma
  • About Us / Contact

Researcher Delivers Promising News on Immunotherapy Role in Mesothelioma

Published on December 15, 2020

Immunotherapy represents real hope in the fight against malignant mesothelioma, as well as in other types of cancer. A presentation delivered at the 5th Annual International Congress on Immunotherapies in Cancer reinforced the sense of optimism, as a top researcher indicated improvements in the results being seen.

Immunotherapy May Move to Front Line Mesothelioma Protocol

Though much of the focus on the use of immunotherapy in malignant mesothelioma has been on its application as a second-line or maintenance therapy after initial treatment with chemotherapy, the latest research is pointing to its role as a frontline protocol. According to Naiyer A. Rizvi, MD, Price Family ​Professor of ​Medicine, director of Thoracic Oncology, and co-director of Cancer Immunotherapy at Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, immunotherapy agents are increasingly yielding better results as an initial application.

“SCLC and mesothelioma have been difficult cancers to treat, and immunotherapy has not made an impact until very recently, where, in the first-line setting, we have improved outcomes and new standards of care for the treatment of SCLC and mesothelioma,” he told a gathering of researchers.

Trial Assessed Outcomes of Opdivo and Yervoy in Mesothelioma Patients 

Dr. Rizvi detailed the use of immunotherapy in the phase 3 CheckMate 743 trial, where patients with malignant pleural mesothelioma are being randomized between doses of Opdivo and Yervoy or the more traditional cisplatin or carboplatin plus pemetrexed treatment. He explained that thus far, the progression free survival rates and the overall survival rates both demonstrate significant improvement with the immunotherapy combination when used in patients with non-epithelioid tumors, and less dramatic results in those with epithelioid tumors. “These data are really meaningful, supporting immunotherapy only as first-line therapy [in mesothelioma],” said Rizvi.

As researchers continue exploring innovative treatments for malignant mesothelioma, having access to up-to-date information becomes more important than ever. For access to the resources you need, contact the Patient Advocates at Mesothelioma.net today at 1-800-692-8608.

FREE Mesothelioma Packet

Written by Terri Oppenheimer

Terri Heimann Oppenheimer
Terri Heimann Oppenheimer is the head writer of our Mesothelioma.net news blog. She graduated from the College of William and Mary with a degree in English. Terri believes that knowledge is power and she is committed to sharing news about the impact of mesothelioma, the latest research and medical breakthroughs, and victims’ stories.

Learn more about and contact Terri
  • Malignant Mesothelioma
    • Treatment
    • Asbestos Trusts
  • Compensation
    • Veteran Assistance
    • Surviving Mesothelioma
  • FREE Mesothelioma Packet
    • Mesothelioma News
    • About Us / Contact
  • Privacy Policy
    • Disclaimer
    • Editorial Guidelines and Standards
This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.
The information provided by Mesothelioma.net is not a substitute for professional medical advice, diagnosis or treatment.

Mesothelioma.net

5430 LBJ Freeway Suite 1200
Dallas, Texas 75240

Serving mesothelioma victims nationwide

1-800-692-8608

  • facebook
  • twitter
© 2022 Mesothelioma.net